ELEVAI Labs Inc
NASDAQ:ELAB
Net Margin
ELEVAI Labs Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
2.2m USD |
-224%
|
|
| US |
|
Kenvue Inc
NYSE:KVUE
|
46.3B USD |
7%
|
|
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD |
-37%
|
|
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
53.8B HKD |
23%
|
|
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
3.6B USD |
16%
|
|
| KR |
A
|
APR Co Ltd
KRX:278470
|
4.3T KRW |
13%
|
|
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
16.6B CNY |
23%
|
|
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
2B EUR |
6%
|
|
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
9.3B CNY |
11%
|
|
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
88.4B INR |
4%
|
|
| ID |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
15.9T IDR |
28%
|
ELEVAI Labs Inc
Glance View
ELEVAI Labs Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Newport Beach, California. The company went IPO on 2023-11-21. Elevai Labs, Inc. is a physician-dispensed skincare company. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare products. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on ELEVAI Labs Inc's most recent financial statements, the company has Net Margin of -223.6%.
You don't have any saved screeners yet